Jazz Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,126,107
$1,045,712
$897,841
$1,088,173
Gross Profit
868,347
929,444
793,221
959,460
EBITDA
235,857
-514,182
138,861
396,981
EBIT
57,611
-688,191
-26,012
228,564
Net Income
251,412
-718,470
-92,541
191,115
Net Change In Cash
1,126,107
1,045,712
897,841
1,088,173
Free Cash Flow
459,441
100,888
390,903
385,293
Cash
1,236,070
1,189,880
1,861,946
2,412,864
Basic Shares
61,606
61,194
60,979
61,503

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$4,068,950
$3,834,204
$3,659,374
$3,094,238
Gross Profit
3,623,237
3,398,627
3,118,857
2,653,478
EBITDA
1,521,711
1,449,422
1,468,615
1,027,746
EBIT
861,644
810,726
839,144
475,263
Net Income
560,120
414,832
-224,060
-328,954
Net Change In Cash
4,068,950
3,834,204
3,659,374
3,094,238
Cost of Revenue
296,256
-463,114
Free Cash Flow
1,347,838
1,068,045
773,783
732,975
Cash
2,412,864
1,506,310
881,482
591,448
Basic Shares
66,007
72,066
62,539
59,694

Earnings Calls

QuarterEPS
2025-09-30
$8.13
2025-06-30
-$8.25
2025-03-31
-$1.52
2024-12-31
$6.60